Study of hALK.CAR T Cells for Patients With Relapsed/Refractory High-risk Neuroblastoma

NCT06803875 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Relapsed Neuroblastoma
Refractory Neuroblastoma
High-risk Neuroblastoma

Interventions

BIOLOGICAL: Autologous hALK.CAR T cells

Sponsor

Roberto Chiarle

Collaborators

[object Object]
[object Object]